-
1
-
-
27544464928
-
Clinical impact and pathogenicity of Acinetobacter
-
Joli-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11:868-873.
-
(2005)
Clin Microbiol Infect
, vol.11
, pp. 868-873
-
-
Joli-Guillou, M.L.1
-
2
-
-
22544477125
-
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
-
Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005; 18:306-313.
-
(2005)
Curr Opin Infect Dis
, vol.18
, pp. 306-313
-
-
Navon-Venezia, S.1
Ben-Ami, R.2
Carmeli, Y.3
-
3
-
-
4644288571
-
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001
-
Sader HS, Jones RN, Gales AC et al. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004; 8:25-79.
-
(2004)
Braz J Infect Dis
, vol.8
, pp. 25-79
-
-
Sader, H.S.1
Jones, R.N.2
Gales, A.C.3
-
4
-
-
4344713310
-
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: Five year report of the SENTRY Antimicrobial Surveillance Program
-
Tognim MCB, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 2004; 8:284-291.
-
(2004)
Int J Infect Dis
, vol.8
, pp. 284-291
-
-
Tognim, M.C.B.1
Andrade, S.S.2
Silbert, S.3
Gales, A.C.4
Jones, R.N.5
Sader, H.S.6
-
5
-
-
25144472273
-
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
-
Thomson JM, Bonomo R. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril! Curr Opin Microbiol 2005; 8:518-524.
-
(2005)
Curr Opin Microbiol
, vol.8
, pp. 518-524
-
-
Thomson, J.M.1
Bonomo, R.2
-
6
-
-
34248334196
-
Comparative review of the carbapenems
-
Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky A. Comparative review of the carbapenems. Drugs 2007; 67:1027-1032.
-
(2007)
Drugs
, vol.67
, pp. 1027-1032
-
-
Zhanel, G.G.1
Wiebe, R.2
Dilay, L.3
Thomson, K.4
Rubinstein, E.5
Hoban, D.J.6
Noreddin, A.M.7
Karlowsky, A.8
-
7
-
-
17644389620
-
Colistin: The revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections
-
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 2005; 40:1333-1341.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1333-1341
-
-
Falagas, M.E.1
Kasiakou, S.K.2
-
8
-
-
0034454247
-
Mechanisms of action and resistance of older and newer fluoroquinolones
-
Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2000; 31:S24-S28.
-
(2000)
Clin Infect Dis
, vol.31
-
-
Hooper, D.C.1
-
9
-
-
0030984308
-
Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations
-
Marques MB, Brookings ES, Moser SA, Sonke PB, Waites KB. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother 1997; 41:881-885.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 881-885
-
-
Marques, M.B.1
Brookings, E.S.2
Moser, S.A.3
Sonke, P.B.4
Waites, K.B.5
-
10
-
-
0032416554
-
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
-
Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Agents Chemother 1998; 42:793-802.
-
(1998)
J Antimicrob Agents Chemother
, vol.42
, pp. 793-802
-
-
Corbella, X.1
Ariza, J.2
Ardanuy, C.3
Vuelta, M.4
Tubau, F.5
Sora, M.6
Pujol, M.7
Gudiol, F.8
-
11
-
-
17644393475
-
Comprehensive in vitro evaluation of cefepime combined with aztreonan or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp
-
Sader HS, Jones RN. Comprehensive in vitro evaluation of cefepime combined with aztreonan or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Int J Antimicrob Agents 2005; 25:380-384.
-
(2005)
Int J Antimicrob Agents
, vol.25
, pp. 380-384
-
-
Sader, H.S.1
Jones, R.N.2
-
12
-
-
33747608427
-
Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species
-
Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43:S95-S99.
-
(2006)
Clin Infect Dis
, vol.43
-
-
Rahal, J.J.1
-
13
-
-
0037512376
-
Methods for dilution antimicrobial tests for bacteria that grow aerobically
-
National Committee for Clinical Laboratory Standards, Wayne, PA: NCCLS;
-
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS; 2003.
-
(2003)
Approved standard M7-A6
-
-
-
14
-
-
84872848836
-
-
Lorian V ed. Antibiotics in Laboratory Medicine. Baltimore, Williams & Wilkins
-
Eliopoulos, GM, Moellering Jr., RC. Antimicrobial Combinations. In: Lorian V ed. Antibiotics in Laboratory Medicine. Baltimore, Williams & Wilkins. 1996: 432-492.
-
(1996)
Antimicrobial Combinations
, pp. 432-492
-
-
Eliopoulos, G.M.1
Moellering Jr., R.C.2
-
15
-
-
3843060294
-
Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections
-
Tascini C, Gemignani G, Ferranti S, Tagliaferri E, Leonildi A, Lucarini A, Menichetti F. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J Chemother 2004; 16:282-287.
-
(2004)
J Chemother
, vol.16
, pp. 282-287
-
-
Tascini, C.1
Gemignani, G.2
Ferranti, S.3
Tagliaferri, E.4
Leonildi, A.5
Lucarini, A.6
Menichetti, F.7
-
16
-
-
0031940776
-
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
-
Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, Schentag JJ. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998; 42:521-527.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 521-527
-
-
Thomas, J.K.1
Forrest, A.2
Bhavnani, S.M.3
Hyatt, J.M.4
Cheng, A.5
Ballow, C.H.6
Schentag, J.J.7
-
17
-
-
0030069091
-
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
-
Cappelletti DM, Rybak MJ. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40:677-683.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 677-683
-
-
Cappelletti, D.M.1
Rybak, M.J.2
-
18
-
-
0035139693
-
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
-
Gradelski E, Kolek B, Bonner DP, Valera L, Minassian B, Fung-Tomc J. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents. Int J Antimicrob Agents 2001; 17:103-107.
-
(2001)
Int J Antimicrob Agents
, vol.17
, pp. 103-107
-
-
Gradelski, E.1
Kolek, B.2
Bonner, D.P.3
Valera, L.4
Minassian, B.5
Fung-Tomc, J.6
-
19
-
-
1442349053
-
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates
-
Jung R, Husain M, Choi MK, Fish DN. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2004; 48:1055-1057.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 1055-1057
-
-
Jung, R.1
Husain, M.2
Choi, M.K.3
Fish, D.N.4
-
20
-
-
1442324767
-
In vitro double and triple synergistic activities of polymyxin B, imipenen, and rifampin against multidrug-resistant Acinetobacter baumannii
-
Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenen, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2004; 48:753-757.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 753-757
-
-
Yoon, J.1
Urban, C.2
Terzian, C.3
Mariano, N.4
Rahal, J.J.5
-
21
-
-
0036498656
-
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
-
Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634-640.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 634-640
-
-
Livermore, D.M.1
-
22
-
-
0033802358
-
Evaluation of antibiotic synergy against Acinetobacter baumannii: A comparison with Etest, time-kill, and checkerboard methods
-
Bonapace RB, White RL, Friedrich LV, Bosso JA. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis 2000; 38:43-50.
-
(2000)
Diagn Microbiol Infect Dis
, vol.38
, pp. 43-50
-
-
Bonapace, R.B.1
White, R.L.2
Friedrich, L.V.3
Bosso, J.A.4
|